<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=ranbaxy&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss"><channel><title>ranbaxy - BingNews</title><link>http://www.bing.com/news/search?q=ranbaxy&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>ranbaxy</title><link>http://www.bing.com/news/search?q=ranbaxy&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Ranbaxy whistleblower reveals how he exposed massive pharmaceutical fraud</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.cbsnews.com%2fnews%2franbaxy-whistleblower-reveals-how-he-exposed-massive-pharmaceutical-fraud%2f&amp;c=16615785438889341571&amp;mkt=en-us</link><description>(CBS News) Among the drugs prescribed to Americans, 80 percent are generic drugs, and 40 percent of drugs are now made overseas in countries such as China and India where U.S. oversight is weaker.</description><pubDate>Wed, 06 Nov 2013 05:57:00 GMT</pubDate><News:Source>CBS News</News:Source></item><item><title>Ranbaxy Recalls Generic Atorvastatin</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.medscape.com%2fviewarticle%2f775082&amp;c=5243969509618723108&amp;mkt=en-us</link><description>PRINCETON, New Jersey — Shortages of generic atorvastatin are possible in the US in the next few weeks after one of the major suppliers, Ranbaxy Laboratories, announced the recall of several batches ...</description><pubDate>Sun, 25 Nov 2012 16:00:00 GMT</pubDate><News:Source>Medscape</News:Source></item><item><title>Ranbaxy’s chronic maladies</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.economist.com%2fbusiness%2f2013%2f09%2f21%2franbaxys-chronic-maladies&amp;c=11429648355208690751&amp;mkt=en-us</link><description>THIS is a golden age for makers of cheap copies of bestselling medicines whose patents have expired. Many of the world’s branded pills are falling off the “patent cliff”, at a time when governments ...</description><pubDate>Fri, 20 Sep 2013 17:00:00 GMT</pubDate><News:Source>The Economist</News:Source></item><item><title>India's Sun Pharma to buy Ranbaxy in $3.2 billion deal</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.cnbc.com%2f2014%2f04%2f06%2findias-sun-pharma-to-buy-ranbaxy-in-4-deal.html&amp;c=17872850224044619265&amp;mkt=en-us</link><description>India's Sun Pharmaceutical Industries said it will buy Ranbaxy Laboratories in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker from two firms struggling with ...</description><pubDate>Sun, 06 Apr 2014 21:20:00 GMT</pubDate><News:Source>CNBC</News:Source></item><item><title>Sun Pharma denies unit's role in Ranbaxy share run-up before deal</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2fsun-pharma-denies-units-role-124837801.html&amp;c=6580421290674307914&amp;mkt=en-us</link><description>Add Yahoo as a preferred source to see more of our stories on Google. MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.NS), which is to buy rival drugmaker Ranbaxy Laboratories Ltd ...</description><pubDate>Mon, 05 May 2014 05:48:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fmanufacturing%2fsun-pharma-loses-bid-to-drop-antitrust-case-against-ranbaxy-jury-trail-set-for-jan-10&amp;c=6725890233055495231&amp;mkt=en-us</link><description>When Sun Pharma acquired troubled Ranbaxy in 2014 for $4 billion, the India generics giant knew it was inheriting some major compliance problems. At the time, four of Ranbaxy’s five plants were ...</description><pubDate>Wed, 24 Nov 2021 02:06:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Ranbaxy back in gear for generic Lipitor production</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fregulatory%2franbaxy-back-gear-for-generic-lipitor-production&amp;c=12326983316318364480&amp;mkt=en-us</link><description>Ranbaxy Laboratories is back in the generic Lipitor saddle again. Three months after stopping production of the cholesterol fighter and recalling almost a half-million bottles, the Indian drugmaker ...</description><pubDate>Mon, 25 Feb 2013 00:18:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Ranbaxy halts production of generic Lipitor after glass particles found</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.foxnews.com%2fhealth%2franbaxy-halts-production-of-generic-lipitor-after-glass-particles-found&amp;c=11461049141964116300&amp;mkt=en-us</link><description>Ranbaxy Laboratories Ltd. has stopped production of its generic version of cholesterol-lowering drug Lipitor as the company investigates what caused tiny glass particles to appear in some bottles, ...</description><pubDate>Fri, 30 Nov 2012 06:42:00 GMT</pubDate><News:Source>Fox News</News:Source></item><item><title>Ranbaxy recalls generic Lipitor doses</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2franbaxy-recalls-generic-lipitor-doses-121005965.html&amp;c=10545662901857537684&amp;mkt=en-us</link><description>TRENTON, N.J. (AP) -- Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string ...</description><pubDate>Fri, 23 Nov 2012 09:47:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>Ranbaxy Launches Authorized Generic Of Evoxac In The U.S. Healthcare Market</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.cnbc.com%2f2012%2f10%2f09%2franbaxy-launches-authorized-generic-of-evoxac-in-the-us-healthcare-market.html&amp;c=9594053860383420749&amp;mkt=en-us</link><description>PRINCETON, N.J., Oct. 9, 2012 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has launched the authorized generic cevimeline ...</description><pubDate>Tue, 09 Oct 2012 05:37:00 GMT</pubDate><News:Source>CNBC</News:Source></item><item><title>Ranbaxy recalls generic Lipitor doses</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a34ac4ead154573878c80a973618cd9&amp;url=https%3a%2f%2fwww.9news.com%2farticle%2fnews%2fhealth%2franbaxy-recalls-generic-lipitor-doses%2f73-333568852&amp;c=10177607017917773103&amp;mkt=en-us</link><description>Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd., India's biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple ...</description><pubDate>Fri, 23 Nov 2012 02:50:00 GMT</pubDate><News:Source>9NEWS</News:Source></item></channel></rss>